2 active not recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 2 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Hematologic Malignancy: new trials by email Literature Review of Hematologic Malignancy trials Research Report on Hematologic Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia CliniMACS® TCRαβ/CD19 Combined Depletion System - Myelodysplasia, Hematologic Malignancy | Phase 1 / Phase 2 | Active not recruiting | Nationwide Children's Hospital | 20 | 2018-03-02 | 2026-04-03 |
| Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant BPX-501 T cells, rimiducid - Hematologic Malignancy | Phase 1 | Active not recruiting | Bellicum Pharmaceuticals | 15 | 2018-02-01 | 2022-07-12 |
Hematologic Neoplasms (2) · Anemia, Refractory, with Excess of Blasts (1) · Leukemia (1) · Lymphoma (1) · Myelodysplastic Syndromes (1) · Neoplasm, Residual (1)
Bone Marrow Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Anemia (1) · Anemia, Refractory (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Myelodysplastic Syndromes (1) · Neoplasms by Histologic Type (1) · Neoplastic Processes (1) · Pathologic Processes (1)
AP 1903 reagent (1)
Bellicum Pharmaceuticals (1) · Nationwide Children's Hospital (1)
Italy (1) · United States (1)